T1D Cutting Edge Research - Episode 29 - Engineering Stem Cell-Derived Beta Cells with Optimized CD155 for Immune Evasion in Type 1 Diabetes Therapy; Brown et al.

In the twenty-ninth episode of "Type 1 Diabetes: Cutting Edge Research" we discuss the paper Engineering Stem Cell-Derived Beta Cells with Optimized CD155 for Immune Evasion in Type 1 Diabetes Therapy.

ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy.

Please note that podcasts were created with the help of notebookLM.